Case report: A kidney transplant patient with mild COVID-19. Transpl Infect Dis 2020 Aug;22(4):e13296
Date
04/18/2020Pubmed ID
32301198Pubmed Central ID
PMC7235513DOI
10.1111/tid.13296Scopus ID
2-s2.0-85083865805 (requires institutional sign-in at Scopus site) 41 CitationsAbstract
Coronavirus Disease 2019 (COVID-19) is currently a pandemic with a mortality rate of 1%-6% in the general population. However, the mortality rate seems to be significantly higher in elderly patients, especially those hospitalized with comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations in immunosuppressed patients, the course of the disease in the transplant patient population is unknown. Hence, the management of these patients with COVID-19 is an area of interest, and a unique approach is warranted. Here, we report the clinical features and our treatment approach for a kidney transplant patient with a diagnosis of COVID-19. We believe that screening protocols for SARS-Cov-2 should be re-evaluated in patients with solid-organ transplants.
Author List
Arpali E, Akyollu B, Yelken B, Tekin S, Turkmen A, Kocak BAuthor
Emre Arpali MD, PhD Associate Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAntiviral Agents
Betacoronavirus
Coronavirus Infections
Cough
Disease Management
Female
Fever
Glucocorticoids
Graft Rejection
Humans
Immunocompromised Host
Immunosuppressive Agents
Kidney Failure, Chronic
Kidney Transplantation
Lupus Nephritis
Oseltamivir
Pandemics
Pneumonia, Viral
Prednisone
Severity of Illness Index
Tacrolimus
